Stockreport

Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation [Yahoo! Finance]

Eledon Pharmaceuticals, Inc.  (ELDN) 
PDF Food and Drug Administration (FDA) has granted Orphan Drug designation to tegoprubart for the prevention of allograft rejection in liver transplantation. Tegoprubart has [Read more]